WP13 Vaccination in Children

COVID-19 mRNA vaccination regimen in children aged 12-16 years

Work package objectives:

While children are much less affected by the (severe) consequences of SARS-CoV-2 infection, paediatric vaccination may prove relevant to maintain low community transmission when lifting non-pharmaceutical interventions. The objective of WP13 is to set-up and conduct paediatric COVID-19 vaccine trials that help inform optimal COVID-19 vaccination strategies in children and adolescents.

WP Lead:

Dr. Patricia Bruijning-Verhagen

Associate Professor Infectious Diseases Epidemiology                                            Julius Centre for Health Sciences and Primary Care, Department of Infectious Diseases Epidemiology
University Medical Centre Utrecht